Gestational mellitus diabetes (GDM) is a highly prevalent metabolic disorder among pregnant women nowadays. It is defined as any level of glucose intolerance, appearing or first being recognized during pregnancy. It is essential to diagnose and treat GDM early, in order to reduce or avoid complications for mother and fetus. Recently, new guidelines have changed the diagnosis criteria, and it is expected that the prevalence of GDM will increase by approximately 18%. A relevant goal of these new definitions is to provide a better care for pregnant women, in an attempt to reduce fetal and maternal complications. These new criteria will also increase the impact on costs of the health care system. Treatment must be individualized for best results, including a specific diet, physical activity and the use of medications. Metformin and Insulin use are analyzed in detail, in face of new evidences regarding their safety and efficacy during pregnancy.
CITATION STYLE
Bortolon, L. N. M., de Paula Leão Triz, L., de Souza Faustino, B., de Sá, L. B. C., Rocha, D. R. T. W., & Arbex, A. K. (2016). Gestational Diabetes Mellitus: New Diagnostic Criteria. Open Journal of Endocrine and Metabolic Diseases, 06(01), 13–19. https://doi.org/10.4236/ojemd.2016.61003
Mendeley helps you to discover research relevant for your work.